Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib

被引：1

作者：

Mondoni, Michele ^{[1
]}

Varone, Francesco ^{[2
]}

Alfano, Fausta ^{[1
]}

Muscato, Giuseppe ^{[3
]}

Conti, Caterina ^{[4
]}

Saderi, Laura ^{[6
]}

Iovene, Bruno ^{[2
]}

Di Marco, Fabiano ^{[4
,5
]}

Vancheri, Carlo ^{[3
]}

Richeldi, Luca ^{[2
]}

Centanni, Stefano ^{[1
]}

Sotgiu, Giovanni ^{[6
]}

机构：

[1] Univ Milan, Dept Hlth Sci, ASST Santi Paolo & Carlo, Resp Unit, Milan, Italy

[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Div Pulm Med, Rome, Italy

[3] Univ Catania, Reg Referral Ctr Rare Lung Dis, AOU Policlin San Marco, Dept Clin & Expt Med, Catania, Italy

[4] ASST Papa Giovanni XXIII, Resp Unit, Bergamo, Italy

[5] Univ Milan, Dept Hlth Sci, Milan, Italy

[6] Univ Sassari, Dept Med Surg & Expt Sci, Clin Epidemiol & Med Stat Unit, Sassari, Italy

来源：

ARCHIVOS DE BRONCONEUMOLOGIA | 2023年 / 59卷 / 07期

关键词：

D O I：

10.1016/j.arbres.2023.02.010

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：464 / 466

页数：3

共 50 条

[1] Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis
Flaherty, Kevin R.
Kolb, Martin
Vancheri, Carlo
Tang, Wenbo
Conoscenti, Craig S.
Richeldi, Luca
EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (02)
[2] Improvement in Patient-Reported Outcomes and Forced Vital Capacity during Nintedanib Treatment of Idiopathic Pulmonary Fibrosis
Takeda, Takayuki
Takeuchi, Mayumi
Saitoh, Masahiko
Takeda, Sorou
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 245 (02): : 107 - 114
[3] Forced Vital Capacity in Idiopathic Pulmonary Fibrosis - FDA Review of Pirfenidone and Nintedanib
Karimi-Shah, Banu A.
Chowdhury, Badrul A.
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1189 - 1191
[4] Improvement In Forced Vital Capacity (FVC) With Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Results From The Inpulsis Trials
Flaherty, K. R.
Kolb, M.
Vancheri, C.
Tang, W.
Conoscenti, C. S.
Richeldi, L.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
[5] The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis
Assayag, D.
Vittinghoff, E.
Ryerson, C. J.
Cocconcelli, E.
Tonelli, R.
Elicker, B.
Golden, J.
Jones, K. D.
King, T. E.
Koth, L. L.
Lee, J. S.
Ley, B.
Wolters, P. J.
Collard, H. R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[6] Effect Of Nintedanib On Decline In Forced Vital Capacity (FVC) Over Time In The Inpulsis® Trials In Patients With Idiopathic Pulmonary Fibrosis
Maher, T. M.
Flaherty, K. R.
Azuma, A.
Cottin, V.
Stansen, W.
Quaresma, M.
Wells, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[7] First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value
Wim A. Wuyts
Martin Kolb
Susanne Stowasser
Wibke Stansen
John T. Huggins
Ganesh Raghu
Lung, 2016, 194 : 739 - 743
[8] Remarkable Improvement in a Patient with Idiopathic Pulmonary Fibrosis after Treatment with Nintedanib
Nakano, Akiko
Ohkubo, Hirotsugu
Fukumitsu, Kensuke
Fukuda, Satoshi
Kanemitsu, Yoshihiro
Takemura, Masaya
Maeno, Ken
Ito, Yutaka
Oguri, Tetsuya
Niimi, Akio
INTERNAL MEDICINE, 2019, 58 (08) : 1141 - 1144
[9] The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis
Assayag, Deborah
Vittinghoff, Eric
Ryerson, Christopher J.
Cocconcelli, Elisabetta
Tonelli, Roberto
Hu, Xiaowen
Elicker, Brett M.
Golden, Jeffrey A.
Jones, Kirk D.
King, Talmadge E., Jr.
Koth, Laura L.
Lee, Joyce S.
Ley, Brett
Shum, Anthony K.
Wolters, Paul J.
Ryu, Jay H.
Collard, Harold R.
RESPIRATORY MEDICINE, 2015, 109 (08) : 1058 - 1062
[10] Reference values for forced vital capacity in idiopathic pulmonary fibrosis
Pereira, Carlos A. C.
RESPIRATORY MEDICINE, 2017, 125 : 102 - 102

← 1 2 3 4 5 →